HPTN 083 interim results: Efficacy of pre exposure prophylaxis (PrEP) containing long acting injectable cabotegravir (CAB LA) is maintained across regions and key populations B Grinsztejn , D Donnell , M Clement , B Hanscom , L Cottle , L Coelho , R Cabello , S Chariyalestak , E Dunne , I Frank , A Gaur , P Gonzalez , TV Ha , J Hinojosa , E Kallas , C Kelley , M Losso , J Valdez Madruga , K Middelkoop , N Phanuphak , J Gallardo , B Santos , O Sued , J Valencia Huanami , C Hucks-Ortiz , N Cardozo , L Monteiro , K Promjantuek , X Mvula , D Jones , S Eshleman , C Blanchette , J Lucas , H Scott , S Fields , K Gomez-Feliciano , A Jennings , J Rooney , W Spreen , D Margolis , A Rinehart , A Adeyeye , M Cohen , M McCauley , R Landovitz , C Vela JOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2020）
AI 理解论文
溯源树
样例
